Status:
UNKNOWN
2940nm Er:YAG Laser and 1927nm Thulium Laser in Improving Atrophic Acne Scars
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Atrophic Acne Scar
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Fractional non-ablative laser (FNAL) has been widely used in improving acne scarring. However, there was only one study reported efficacy and safety of the fractional non-ablative 1927nm thulium laser...
Detailed Description
Acne vulgaris is a chronic and recalcitrant inflammation of pilosebaceous unit that has a high incidence rate in adolescence and even adults. Acne scarring is not an uncommon cosmetic complication whi...
Eligibility Criteria
Inclusion
- age of at least 18 years clinical diagnose of facial atrophic acne scarring
Exclusion
- there was infection in the treatment site Acne vulgaris were not controlled had a propensity for keloid forming received oral isotretinoin or laser treatment in the past 3 months received chemical peeling 1 month before the study pregnancy or breast-feeding.
Key Trial Info
Start Date :
June 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04813419
Start Date
June 11 2020
End Date
April 1 2021
Last Update
March 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhejiang University
Hangzhou, Zhejiang, China, 0571